Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 7 min ago
PreprintAll rights reservedbioRxiv

Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1

  • M. D. Shmueli
  • T. Yongfeng
  • E. Singh
  • M. P. Kramer
  • A. Abramov
  • T. Aizik
  • D. Sheban
  • A. Lobov
  • K. Goldberg
  • A. Ibraheem
  • R. Shteinvil
  • A. Javitt
9 more authors
  • Y. Levin
  • M. A. Schafroth
  • D. Ogasawara
  • J. Gross
  • F. Adolf
  • B. Melillo
  • B. A. Schulman
  • B. F. Cravatt
  • Y. Merbl1
  1. 1The Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel
Read full textPDFDOICite

Related

  1. Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy
    Naiyu Liu, Yingrui Wei, Shanshan Fu +2
    ACS OmegaPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  2. Targeting N-acetyltransferase 10 reprograms Treg function to enhance anti-PD-1 immunotherapy sensitivity in murine lung tumors.
    Xuewei Qi, Dan Cui, Xiao Li +20
    The Journal of clinical investigationPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer
    J. Yang, T. S. HILLIARD, Y. LIU +12
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics
    Laura I. Yousif, Wouter C. Meijers, Rudolf A. de Boer
    JACC: CardioOncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  5. Potential role of resveratrol in abdominal cocoon syndrome: targeting inflammation, oxidative stress, and fibrosis via food-derived bioactive compounds resveratrol for treatment of abdominal cocoon syndrome
    Hailong Guo, Minglei Bi
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{shmueli2026targeting,
  title = {{Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1}},
  author = {M. D. Shmueli and T. Yongfeng and E. Singh and M. P. Kramer and A. Abramov and T. Aizik and D. Sheban and A. Lobov and K. Goldberg and A. Ibraheem and R. Shteinvil and A. Javitt and Y. Levin and M. A. Schafroth and D. Ogasawara and J. Gross and F. Adolf and B. Melillo and B. A. Schulman and B. F. Cravatt and Y. Merbl},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.15.759172},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.15.759172v1},
}
RIS
TY  - UNPB
TI  - Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1
AU  - M. D. Shmueli
AU  - T. Yongfeng
AU  - E. Singh
AU  - M. P. Kramer
AU  - A. Abramov
AU  - T. Aizik
AU  - D. Sheban
AU  - A. Lobov
AU  - K. Goldberg
AU  - A. Ibraheem
AU  - R. Shteinvil
AU  - A. Javitt
AU  - Y. Levin
AU  - M. A. Schafroth
AU  - D. Ogasawara
AU  - J. Gross
AU  - F. Adolf
AU  - B. Melillo
AU  - B. A. Schulman
AU  - B. F. Cravatt
AU  - Y. Merbl
PY  - 2026
DA  - 2026/10/15
PB  - bioRxiv
DO  - 10.64898/2026.10.15.759172
UR  - https://www.biorxiv.org/content/10.64898/2026.10.15.759172v1
ER  -